0001181431-12-042507.txt : 20120727 0001181431-12-042507.hdr.sgml : 20120727 20120727164135 ACCESSION NUMBER: 0001181431-12-042507 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120725 FILED AS OF DATE: 20120727 DATE AS OF CHANGE: 20120727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seely Lynn CENTRAL INDEX KEY: 0001327111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 12991111 MAIL ADDRESS: STREET 1: 501 2ND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 4 1 rrd351729.xml LYNN SEELY -- 7/25/12 EXERCISE AND SALE X0306 4 2012-07-25 0 0001011835 MEDIVATION, INC. MDVN 0001327111 Seely Lynn C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105 0 1 0 0 Chief Medical Officer Common stock 2012-07-25 4 M 0 2400 34.56 A 23911 D Common Stock 2012-07-25 4 S 0 2400 98.0077 D 21511 D Common Stock 2012-07-26 4 M 0 37600 34.56 A 59111 D Common Stock 2012-07-26 4 S 0 32094 99.6358 D 27017 D Common Stock 2012-07-26 4 S 0 5506 100.2732 D 21511 D Stock Option (Right to Buy) 34.56 2012-07-25 4 M 0 2400 0.00 D 2019-12-15 Common Stock 2400 91600 D Stock Option (Right to Buy) 34.56 2011-07-26 4 M 0 37600 0.00 D 2019-12-15 Common Stock 37600 54000 D Shares sold pursuant to a 10b5-1 Plan. The shares were sold at prices ranging from $98.00 to $98.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares subject to the option vest according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) vested on December 15, 2012, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) vest of the first day of each full month thereafter. The shares were sold at prices ranging from $98.99 to $99.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $99.99 to $100.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ C. Patrick Machado, Attorney-in-fact 2012-07-27